Abstract: An illustrative example hydrogen concentration sensor includes a hydrogen chamber configured to isolate hydrogen within the hydrogen chamber from gas outside the hydrogen chamber. A hydrogen evolving electrode is configured to generate pure hydrogen within the hydrogen chamber. A reference electrode is situated to be exposed to pure hydrogen within the hydrogen chamber. A detection electrode associated with the reference electrode is situated to be exposed to gas outside the hydrogen chamber. The detection electrode is configured to provide an indication of a concentration of hydrogen in the gas outside the hydrogen chamber.

Abstract: A plant support system includes a support ring having at least one wall portion, and at least one support beam coupled to the at least one wall portion and configured to increase rigidity of the at least one wall portion. Further, the plant support system also includes a base coupled to the at least one wall portion and having at least one stationary clamping surface; a clamp spine having a movable clamping surface situated opposite the at least one stationary clamping surface; and a plurality of spring leaves coupled to the clamp spine and configured to bias the clamp spine.

Abstract: An illustrated example method of making a porous carbon composite includes mixing a carbon-based material, a binder and pore former particles to establish a mixture. The mixture is placed into a mold where it is subjected to pressure at an ambient temperature to form a compacted body. Subsequently, the compacted body is heated to a temperature that causes at least partial removal of the pore former particles to establish pores in place of at least some of the pore former particles.

Abstract: An artificial intelligence testing apparatus may include processing circuitry configured to execute instructions that, when executed, cause the apparatus to create initial sample points based on a simulation received at the apparatus, and employ cyclic evaluation of the simulation until a stopping criteria is met. Employing the cyclic evaluation includes running the simulation at design points for a set of queries associated with a current iteration of the cyclic evaluation, training a set of meta-models of parameter space associated with the simulation for the current iteration, computing a set of metrics for the current iteration, and employing a selected sampling approach to select a new set of design points for a next iteration of the cyclic evaluation.

Abstract: Through a first processing thread, a first database is accessed via a first API to retrieve a list of event objects of the first database. Through a second processing thread, for each of the event objects, participant identifiers (IDs) are determined from the event object. For each of the participant IDs, a domain ID is extracted from the participant ID. A list of one or more entity objects are identified based on the domain ID, where the entity objects are stored in a second database such as a task database storing and managing many tasks. At least one attribute of at least one of the entity objects is modified based of the participant ID and the domain ID, which generates a modified entity object. Through a third processing thread, any event objects that have been modified are transmitted to the second database via a second API over the network.

Abstract: An illustrative example fuel cell assembly includes at least one cooler and a plurality of fuel cells each having an anode and a cathode. Each of the anodes includes an anode flow plate configured to allow fuel to flow through the anode. The anode flow plates have a respective flow resistance that varies among at least some of the anodes based on a distance between the corresponding anode and the cooler.

Abstract: The disclosure relates to compounds of formula (I) and pharmaceutically acceptable salts, and compositions thereof, wherein the substituents are as defined herein. Also provided are methods of making compounds of formula (I), and methods involving the compounds or compositions for treating disorders and diseases described herein.

Abstract: An illustrative example fuel cell manifold assembly includes a metal manifold pan. A polymer material liner that is self-supporting includes a primary wall situated adjacent an interior of the manifold pan. The liner has a channel around a periphery of the liner and a portion of the manifold is received in the channel. A reactant conduit adapter is received through respective openings in the manifold pan and the liner. The reactant conduit adaptor includes a flange that is received against an interior surface on the primary wall of the liner with an interface between the flange and the interior surface being sealed. Another portion of the reactant conduit adaptor is adjacent an exterior of the manifold pan that faces in an opposite direction from the interior surface on the primary wall.

Abstract: An illustrative example embodiment of a fuel cell manifold device includes a self-supporting polymer material liner body including a generally planar primary wall and a plurality of side walls. The side walls respectively extend generally perpendicularly from the primary wall. Interior surfaces on the primary wall and the side walls collectively define a cavity. The primary wall has a length and a width that is smaller than the length. The primary wall includes a plurality of ribs situated width wise along the primary wall. The ribs are spaced apart from each other in a lengthwise direction. The ribs allow for some thermal expansion of the liner body.

Abstract: An illustrative example embodiment of a fuel cell manifold device includes a self-supporting polymer material liner body including a generally planar primary wall and a plurality of side walls. The side walls respectively extend generally perpendicularly from the primary wall. Interior surfaces on the primary wall and the side walls collectively define a cavity. The primary wall has a length and a width that is smaller than the length. The primary wall includes a plurality of ribs situated width wise along the primary wall. The ribs are spaced apart from each other in a lengthwise direction. The ribs allow for some thermal expansion of the liner body.

Abstract: A device for assembling aggregations of adherent cells includes a gripper moveable within an assembly vessel that fixes aggregations of adherent cells at a membrane of the gripper and, by movement of the gripper, assembles aggregations of cells on a separate membrane within the vessel, thereby creating a three-dimensional assembly of aggregations of cells that fuse and can be employed in surgical procedures as a unitary tissue of adherent cells. The aggregations of cells, as assembled, can assume three-dimensional configurations distinct from any one of the component aggregations of cells assembled.

Abstract: The invention generally relates to the field of immunochemistry including antibody therapy, diagnostics, and basic research and specifically relates to the area of selecting affinity molecules such as natural antibodies, including artificial antibodies, antibody mimics, and aptamers. The invention relates particularly to a method of selecting affinity molecules using a homogeneous noncompetitive assay in a high throughput process.

Abstract: The present disclosure provides systems for storing electrical energy. A system for storing energy comprises a plurality of separable energy storage devices that are operatively connected in series or parallel. Each energy storage device of the plurality comprises a housing that includes a magnet that generates a magnetic field, an armature coil that rotates relative to the magnetic field upon user movement of the housing or the armature coil, and an energy storage unit electrically coupled to the armature coil and adapted to store electrical energy generated upon rotation of the armature coil in the magnetic field.

Abstract: The invention generally relates to the field of immunochemistry including antibody therapy, diagnostics, and basic research and specifically relates to the area of selecting affinity molecules such as natural antibodies, including artificial antibodies, antibody mimics, and aptamers. The invention relates particularly to a method of selecting affinity molecules using a homogeneous noncompetitive assay in a high throughput process.

Abstract: Orthopedic fracture repair implants, systems and methods are disclosed. Implants include one or more biocompatible sleeves and struts. The implants, systems and methods are applied to bone fractures, such as segmentation fractures.

Abstract: The invention generally relates to the field of immunochemistry including antibody therapy, diagnostics, and basic research and specifically relates to the area of selecting affinity molecules such as natural antibodies, including artificial antibodies, antibody mimics, and aptamers. The invention relates particularly to a method of selecting affinity molecules using a homogeneous noncompetitive assay in a high throughput process.

Abstract: A device for assembling aggregations of adherent cells includes a gripper moveable within an assembly vessel that fixes aggregations of adherent cells at a membrane of the gripper and, by movement of the gripper, assembles aggregations of cells on a separate membrane within the vessel, thereby creating a three-dimensional assembly of aggregations of cells that fuse and can be employed in surgical procedures as a unitary tissue of adherent cells. The aggregations of cells, as assembled, can assume three-dimensional configurations distinct from any one of the component aggregations of cells assembled.

Abstract: Orthopedic fracture repair implants, systems and methods are disclosed. Implants include one or more biocompatible sleeves and struts. The implants, systems and methods are applied to bone fractures, such as segmentation fractures.

Abstract: The invention generally relates to the field of immunochemistry including antibody therapy, diagnostics, and basic research and specifically relates to the area of selecting affinity molecules such as natural antibodies, including artificial antibodies, antibody mimics, and aptamers. The invention relates particularly to a method of selecting affinity molecules using a homogeneous noncompetitive assay in a high throughput process.

Abstract: The invention generally relates to the field of immunochemistry including antibody therapy, diagnostics, and basic research and specifically relates to the area of selecting affinity molecules such as natural antibodies, including artificial antibodies, antibody mimics, and aptamers. The invention relates particularly to a method of selecting affinity molecules using a homogeneous noncompetitive assay in a high throughput process.